Home

Safety and Efficacy of Combining nbUVB to Etanercept in Patients

Study Description: 
This study will provide data on the addition of nbUVB phototherapy to patients who have not shown an excellent response to three months of etanercept.
Skin Disease: 
Psoriasis
Study Start Date: 
April 2008
Estimated completion date: 
August 2009
Study Location(s): 
Laval
Province: 
Quebec
Agegroup: 
18+ years
Gender: 
Both
Healthy Volunteers: 
No
Study Director/Investigator: 
Robert Bissonnette, MD
Contact: 
Pierre Lebeau (514) 521-3111 ext 233

Contact Information:

Canadian Skin Patient Alliance
2446 Bank Street, Suite 383
Ottawa, Ontario
K1V 1A8
 

Sheri Pilon, Program & Services Manager
phone: 613-224-4266
fax: 613-422- 4267
 

pageTracker._trackPageview();